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There are many reports which demonstrate that the rate of protein biosynthesis at the elongation stage is actively regulated in eukaryotic cells. 
Possible physiological roles for this type of regulation are: the coordination of translation of mRNA with different initiation rate constants; regula- 
tion of transition between different physiological states of a cell, such as transition between stages of the cell cycle: and in general, any situation 
where the maintenance of a particular physiological state is dependent on continuous protein synthesis. A number of covalent modifications of 
elongation factors offer potential mechanisms for such regulation. Among the various modifications of elongation factors, phosphorylation of eEF-2 
by the specific CaZ”/calmodulin-dependent eEF-2 kinase is the best studied and perhaps the most important mechanism for regulation of elongation 
rate. Since this phosphorylatidn is strictly Ca*+-dependent, and makes eEF-2 inactive in translation. this mechanism could explain how changes 
in the intracellular free Cat+ concentration may regulate elongation rate. We also discuss some recent findings concerning elongation factors. such 
as the discovery of developmental stage-specific elongation factors and the regulated binding of eEF-lor to cytoskeletal elements. Together, these 
observations underline the importance of the elongation stage of translation in the regulation of the cellular processes essential for normal cell 
life. 
Regulation of translation; Elongation factor; Protein phosphorylation; CaZ+/calmodulin-dependent protein kinase 
1. INTRODUCTION 
Translation consists of three principal stages: initia- 
tion, elongation and termination. Most studies concern- 
ing the regulation of protein synthesis in eukaryotes are 
about regulation at the initiation stage. However, there 
is a significant amount of experimental data offering 
ciear evidence for the existence of regulatory 
mechanisms at the elongation stage. Moreover, recent 
reports demonstrate the importance of this regulation 
in the control of various physiological processes, such 
as those governing cell proliferation and differentia- 
tion. In this review we summarize these results and 
discuss their possible implications. 
2. EVIDENCE FOR THE REGULATION OF THE 
ELONGATION RATE 
The rate of polypeptide chain elongation on total 
mRNA or on specific cellular mRNA was reported to 
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vary depending on the stimulus, e.g. hormone treat- 
ment, viral infection, egg fertilization. In the following 
paragraphs we describe several examples where such 
changes in elongation rate were clearly demonstrated. 
Addition of serum to HeLa cells resulted in a two- to 
three-fold increase in the overall elongation rate [l]. A 
significant change in the overall elongation rate was 
reported for human placental explants during normal 
placental development and in diabetic pregnancies [2]. 
The injection of estradiol into cockerels induced inhibi- 
tion of the overall eIongation rate in liver cells from an 
average value of seven amino acids per second per 
ribosome, to five amino acids per second after one day, 
three amino acids per second after two days and two 
amino acids per second after three ,days [3]. In- 
traperitoneal glucagon administration produced tem- 
porary inhibition of the elongation rate in rat liver 141. 
The infection of mouse L cells with encephalomyocar- 
ditis virus led to a drastic slowing of polypeptide 
elongation on host mRNA, from 9-10 amino acids per 
second per ribosome down to two amino acids per se- 
cond within five hours after infection [5]. The fertiliza- 
tion of sea urchin eggs was accompanied by a two-fold 
increase of the overall elongation rate [6,7]. During 
yeast-to-hyphae morphogenesis in the fungus Mrtcar 
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racemosus a four-fold rise of the elongation rate was 
observed [8]. 
through modification or alteration of the concentration 
There are also examples where the elongation rate on 
a specific mRNA is significantly changed, while a 
relatively small effect is observed in the overall elonga- 
tion rate. In the cockerel liver, one day after estradiol 
injection, the elongation rate for vitellogenin was 
reported to be about nine amino acids per second per 
ribosome. That for serum albumin was just two amino 
acids per second, and thus, reduced compared with the 
elongation rate of average cellular polypeptides which 
was about five amino acids per second [9]. An exquisite- 
ly selective effect was observed in cultured hepatoma 
cells: their exposure to dibutyryl cyclic AMP resulted in 
no change in the elongation rate of the total protein (ap- 
proximately two amino acids per second per ribosome) 
whereas the elongation rate for tyrosine aminotrans- 
ferase was increased to ten amino acids per second [ 101. 
In rat liver, the elongation rate for ornithine amino- 
transferase was shown to be stimulated by the ad- 
ministration of a diet high in protein, in contrast to that 
for total protein which was somewhat reduced [l 11. 
of any component pa.rticipating in the elongation cycle, 
such as ribosomes, aminoacyl-tRNA synthetases, 
tRNA, elongation factors or even GTP. In reality, there 
is more evidence in favor of elongation factors as 
primary targets for regulation of the elongation rate. 
There are several exarnples where a change in the overall 
rate of protein synthesis has been demonstrated to cor- 
relate with elongation factor activity. This was the case 
in toad-fish liver during cold acclimation [ 123, in 
cultured mammalian cells depending on the presence of 
serum [13,14], in rat liver after thyroidectomy 115,161, 
in sea urchin eggs as a result of fertilization [17], in rat 
spleen during the immune response [lg], as well as dur- 
ing ageing in rat liver [19], in Drosophila 1201, and in 
human cell lines [tl]. The nature of the modification 
responsible for the alteration of elongation factor ac- 
tivity in these cases remains unknown. However, the ex- 
istence of several covalent modifications of both 
elongation factors has been reported (Table I). 
The examples mentioned above, demonstrate that 
changes in the elongation rate are indeed observed 
under different physiological situations. However, the 
identity of second messenger systems involved in the 
transduction of the external signal to the translational 
machinery, as well as which components of the transla- 
tion apparatus are affected, remained undefined. These 
problems, and the potential physiological role for the 
observed changes in the elongation rate, are addressed 
in the following sections. 
3. COVALENT MODIFICATION OF 
ELONGATION FACTORS COULD BE 
RESPONSlBLE FOR THE REGULATION OF 
THE ELONGATION RATE 
Elongation factor-l (eEF-1) is composed of three 
subunits: CY (50 kDa), P (32 kDa) and y (48 kDa). All 
three subunits are subject to covalent modifications. 
eEF-lar can be methylated [22-261, phosphorylated [27] 
and modified with glycerylphosphoryl-ethanolamine 
[26,28,29]. The role of the latter two modifications is 
completely unclear. Concerning methylation of eEF-la 
in the fungus Mucor r~cemosus, it was found that the 
observed increase of melhylation correlated with the 
elevation in the overall elongation rate during the yeast- 
to-hyphae transition. The reduction of methylation cor- 
related with the decrease in eEF-1 activity during spore 
germination [25]. In contrast, purified hypo- or hyper- 
methylated eEF-la were equally active in partial reac- 
tions of the elongation cycle in vitro [30]. 
In theory, the elongation rate can be regulated 
Phosphorylation of eEF-10 was reported in Artemia 
[31] and wheat embryos [32] presumably due to the 
presence of an intrinsic protein kinase in the prepara- 
tions of eEF-1. The effect of eEF-l/3 phosphorylation 
Table 1 
Elongation factor 
eEF-lot 
Covalent modifications of elongation factors 
Type of modification Site References 
methylation Lys-55, L.ys-165 (dimethyllysine) [22-261 
Lys-36, Lys-79, Lys-3 I8 
(trimethyllysine) 
pliosphorytation ? (271 
attachment of glyceryl Glu-301, Glu-374 [26,28,29] 
phosphorylethanolamine 
cEF-10 phosphorylation Ser.89 [311 
eEF-ly 
eEF2 
phosphorylation 
formation of diphtatnide 
phosphorylation 
? 
His-714 
Thr-53, Thr-56, Thr-S8 
Ser? Tyr? 
[33,591 
1341 
[39,401 
~721 
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on eEF-1 activity is unclear: both stimulation [32] and 
inhibition [31] were reported in vitro. 
-I-he most intriguing modification is the phosphoryla- 
tion of eEF-ly catalysed by maturation promoting fac- 
tor (~34”~‘~ kinase) [33,59]. Since ~34~‘/” protein kinase 
has now been shown to be a universal regulator of 
mitosis and cell cycle progression in eukaryotes, this 
finding suggests a possibility of the involvement of 
eEF-1 in the regulation of cell cycle traverse. It is dif- 
ficult to speculate on this since the function of eEF-17 
is as yet unknown. 
There are also several covalent modifications of 
eEF-2. The best described being the modification of 
His-714 into diphthamide (cf. 1341 for review). Diphth- 
amide is a trivial name for 2-[3-carboxyamido-3- 
(trimethyl-ammonio)propyl]histidine and at least five 
enzymes participate in this modification. eEF-2 can 
be ADP-ribosyIat,ed at the diphthamide residue by 
diphtheria and Pseudomonas toxins, thereby rendering 
eEF-2 inactive in translation (reviewed in [34]). The 
physiological role of diphthamide is unknown. The 
most recently described modification of eEF-2 is 
phosphorylation on threonine residues (reviewed in 
[35]) and on serine and tyrosine residues (721. The 
phosphorylation of eEF-2 on threonine requires special 
attention because it has been clearly shown to play an 
important role in the regulation of protein synthesis. 
4. Ca2 + /CALMODULIN-DEPENDENT 
PHOSPHORYLATION OF eEF-2: THE LINK 
BETWEEN THE EXTERNAL SIGNAL AND 
PROTEIN SYNTHESIS 
Phosphorylation of eEF-2 was recently found to be 
the most prominent and rapid phosphorylation in mam- 
malian cell extracts [36] (reviewed in [35]). It is catalyz- 
ed by a specific Ca’ + /calmodulin-dependent protein 
kinase called Ca2 + /calmoduIin-dependent protein 
kinase III [37] or eEF-2 kinase [38]. This kinase phos- 
phorylates threonine residues in the N-terminal part of 
eEF-2 [39,40]. 
In contrast to many other phosphorylations of pro- 
teins involved in translation, phosphorylation of eEF-2 
has a strong effect on its activity. Phosphorylated 
eEF-2 is inactive in a poly(U)-directed cell-free transla- 
tion system [41-431 because it is unable to catalyze 
ribosome translocation [44]. Phosphorylation of eEF-2 
can also affect translation of natural mRNA, as shown 
in a cell-free system based on the rabbit reticulocyte 
lysate. For example, the CAMP-dependent activation of 
globin mRNA translation in a rabbit reticulocyte cell- 
free translation system was shown to correlate with 
dephosphorylation of eEF-2 [45]. Inhibition of globin 
mRNA translation by the phosphatase inhibitor oka- 
daic acid, was found to correlate with the subsequent 
increase in the amount of the phosphorylated form of 
eEF-2 [46]. It was also shown that phosphorylated 
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eEF-2 was unable to restore translation of globin 
mRNA after addition to the eEF-2-depleted rabbit 
reticulocyte ceil-free translation system [47] whereas ad- 
dition of the unphosphorylated form could. 
eEF-2 becomes intensely phosphorylated in vivo in 
response to elevation of the cytoplasmic Ca* + concen- 
tration. This was shown in the case of treatment of 
quiescent Ruman fibroblasts with mitogens [48] or 
treatment of human umbilical vein endothelial cells 
with thrombin or histamine [49]. In both cases, the in- 
crease in eEF-2 phosphorylation was transient and con- 
tinued for just a few minutes [48,49]. Since almost 
100% of the total cellular eEF-2 was! phosphorylated 
under these conditions [49], one would expect that this 
would result in a transient shut-off of protein synthesis. 
Phosphorylation of eEF-2 may also be a mechanism 
by which protein synthesis could be inhibited during 
mitosis. It is well known, that protein synthesis is 
decreased during mitosis, but the molecular mechanism 
of this is unknown. During mitosis, there is an increase 
in Cat’ concentration (reviewed in [SO]). When 
changes in the level of phosphorylated eEF-2 were in- 
vestigated throughout the cell cycle of transformed 
human amnion cells, a dramatic increase in the level of 
phosphorylated eEF-2 was found specifically in mitosis 
[5 11. Together, these observations support the postulate 
that the regulation of the phosphorylation state of 
eEF-2, represents a mechanism via which cytoplasmic 
free Ca” concentration could modulate the rate of 
protein synthesis. 
5. CHANGES IN THE ELONGATION RATE CAN 
AFFECT GENE EXPRESSION IN DIFFERENT 
WAYS 
In previous sections we presented several examples of 
changes in the rate of polypeptide chain elongation in 
vivo, as well as several post-translational modifications 
of elongation factors which could be responsible for 
such changes. There are at least three possible ways via 
which changes in the rate of elongation can affect the 
steady-state level of a given protein in a cell, These 
possibilities are discussed below. 
5.1. Stimulation of translation of ‘weak’ nd?NA 
through inhibition of the overall elongation rate 
Cellular mRNAs have various initiation rate con- 
stants and can be classified into two categories: ‘strong’ 
(with high constant for initiation) and ‘weak’ (with low 
constant for initiation). Under the most common condi- 
tion:;, the rate-limiting stage in translation in vivo is in- 
itiation. Under these conditions, different mRNAs are 
translated according to their ‘strength’ rather than their 
concentrations. Thus, ‘strong’ mRNAs have an advan- 
tage over ‘weak’ mRNA during translation. As 
originally pointed out by Lodish [52], the inhibition of 
overall elongation rate has a more pronounced effect on 
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the translation of ‘strong’ mRNA than of ‘weak’ 
mRNA. This is due to the fact that when the elongation 
stage becomes rate-limiting, the efficiency of transla- 
tion of each mRNA is determined by the relative 
amount of that mRNA. Thach and his colleagues 
1[53-581 further developed this model demonstrating 
both theoretically and experimentally that inhibition of 
overall elongation rate could actually stimulate transla- 
tion of “weak’ mRNA. This is due to the existence of 
specific initiation factor(s) which can be limiting in 
translation and have different affinities for different 
mRNAs. Reduction of the elongation rate, makes 
elongation rate-limiting only on ‘strong’ mRNAs. 
Thus, translation of ‘weak’ mRNA is stimulated by 
mobilization of the limiting initiation factor from 
‘strong’ mRNA. For example, when protein synthesis 
in mouse fibroblasts was partially inhibited by 
cycloheximide, the synthesis of several polypeptides 
was stimulated [57,58]. 
5.2. Effect of elongation rate changes on rnRNA 
stability 
There are numerous examples where mRNA stability 
is dependent on ongoing protein synthesis. In some 
cases, inhibition of elongation results in stabilization of 
mRNA, probably by simple physical protection of 
mRNA by the stalled ribosomes. In other cases, a quite 
opposite effect is observed: inhibition of elongation 
results in the stimulation of mRNA degradation. The 
behaviour of cr-tubulin mRNA illustrates both situa- 
tions: a 95070 inhibition of protein synthesis in mouse 
fibroblasts with the elongation inhibitor cycloheximide, 
resulted in enhanced degradation of a-tubulin mRNA, 
while a 99% inhibition of protein synthesis stabilized 
the a-tubulin mRNA [60]. 
5.3. Inhibition of the elongation rate and elimination 
of short-lived proteins 
Recently, it became evident that there are proteins in 
the cell that have extremely short half-lives [61]. For ex- 
ample the (x2 repressor in yeast has a half-life of - 5 
min [62]. The steady-state levels of such proteins could 
be regulated by changes in the overall elongation rate. 
If cells contain a repressor of transcription or transla- 
tion having a half-life of several minutes, it is very easy 
to imagine how a transient block of elongation could 
result in elimination of such a repressor, thereby 
resulting in an apparent induction of transcription or 
translation of the gene or mRNA repressed by this 
short-lived protein. 
6. POSSIBLE ROLE FOR THE REGULATION OF 
ELONGATION RATE 
Two main roles for regulation of protein synthesis at 
the elongation stage can be proposed. Since it is possible 
to affect translation of ‘weak’ and ‘strong’ mRNA dif- 
ferentially (see above) by decreasing the overall rate of 
elongation, regulation at the elongation stage could 
serve to coordinate translation of selected mRNA. This 
could be important in the case of activation of certain 
cells and tissues by hormones or in the case of fertiliza- 
tion, when a large amount of new mRNA is mobilized 
for translation. If these new mRNAs have very high rate 
constants for initiation, the sudden demand for their 
translation could limit the availability of initiation fac- 
tors and thus favor the synthesis of new proteins at the 
expense of that of constitutive proteins. For example, 
estradiol injection into cockerels was demonstrated to 
cause a rapid increase in the amount of specific mRNA 
in the liver, together with a decrease in the overall 
elongation rate [3]. The most evident explanation for 
the role of this decrease in elongation rate is that it 
could minimize translational discrimination and hence, 
prevent interruption of synthesis of constitutive pro- 
teins when many egg-related proteins begin to be syn- 
thesized. 
Another process in which regulation at the elongation 
stage could be important is transition of a cell from one 
physiological state, dependent on continuous protein 
synthesis, into another. For example, maintenance of 
the quiescent state in some types of cells is dependent on 
continuous protein synthesis as illustrated by the fact 
that transient inhibition of elongation results in transi- 
tion of the cells to a proliferative state [63]. Similarly, 
metaphase arrest during meiotic maturation of oocytes 
from different vertebrates and invertebrates is depen- 
dent on continuous protein synthesis and can be over- 
come by inhibition of elongation rate. This was shown 
in the case of metaphase II arrest in mouse oocytes [64] 
and metaphase I arrest in oocytes of the annelid 
Chaetopterus [65], the mollusc Patek [66] and the 
mollusc Mytilus [67]. 
Usually, the fact that protein synthesis inhibition can 
induce transition of a cell into a new physiological state, 
is explained in the literature by the presence of short- 
lived proteins which maintain the cell in the initial state. 
It should be mentioned, however, that an additional ex- 
planation can be applicable in some cases. As we 
already discussed, inhibition of elongation could not 
only result in elimi.nation of short-lived proteins, but it 
could also result in a change in the stability of, or in- 
duce the translation of, specific physiologically critical 
mRNAs. 
7. RECENT FINDINGS 
7.1. Developmental stage-specific elongation factors 
Recently, it was found that in Drosophila, there are 
two genes for eEF-la. One, called Fl, is expressed in all 
cells at every stage of development, while another, F2, 
is expressed mainly during the pupal stage [68]. 
In Xenopus, three genes for eEF-la were identified 
[69]. One gene is expressed in somatic cells while 
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another is expressed in oocytes 169,701. The third gene 
encodes a form of eEF-Iar called thesaurin-a. 
Thesaurin-a is a component of a 42 S ribonucleoprotein 
particle, consisting mainly of aminoacyl-tRNA, that is 
present at early stages of oogenesis [69,7 l]. The role of 
these forms of &F-la is unknown. The situation 
becomes even more puzzling in the light of results of a 
recent publication 1711 where it was found, that while 
thesaurin-a is distributed uniformly throughout the 
cytoplasm of pre-vitellogenic oocytes, the oocyte- 
specific form of eEF-la is concentrated in, or near, the 
Balbiani body which is the large mitochondria of small 
oocytes. 
7.2. Binding of eEF-I to actin and other 
macromolecules 
Binding of eEF-1 to different cellular proteins has 
been reported recently. Complexes between SF-1 and 
valyl-tRNA synthetase have been isolated from dif- 
ferent mammalian tissues [73-751. It has been found 
that the entire cellular complement of valyl-tRNA syn- 
thetase is present in a complex with eEF-1 [73-753. It 
has also been demonstrated, that eEF-lcr can bind to 
t.he components of the sea urchin mitotic apparatus and 
that it represents the major GTP-binding protein 
therein [76,77]. 
Another recent discovery is the observation that 
eEF-la is the major actin-binding protein from Dic- 
tyostelium [78]. It was observed, that eEF-la can bind 
both G-actin and F-actin [78]. However, while F-actin 
has no effect on the eEF-lcu activity in a cell-free 
system, binding to G-actin completely inhibits eEF-la 
activity [79]. This observation raises an intriguing 
possibility that binding of eEF-lr~ to actin can be a sen- 
sory mechanism which regulates the rate of protein syn- 
thesis in response to cytoskeletal rearrangements. 
7.3. Prolongation of life by eEF-la 
The most exciting recent finding concerning elonga- 
tion factors is the influence of eEF-la! mRNA concen- 
tration on the lifetime of the fruit fly. It was previously 
reported that, during ageing in Drosophi/a, there is a 
selective decrease in the amount of mRNA for eEF-la 
[20]. When Drosophila were transformed with a P- 
element vector containing the eEF-la! gene, the mean 
lifetime of transformed flies was 20-40% longer than 
that of wild type flies [80], 
This observation, together with the others described 
in this review, argues strongly in favor of a paramount 
role for the regulation of protein synthesis at the 
elongation stage in the modulation of gene expression. 
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